Generic placeholder image

Combinatorial Chemistry & High Throughput Screening

Editor-in-Chief

ISSN (Print): 1386-2073
ISSN (Online): 1875-5402

Research Article

Network Pharmacology Studies on the Molecular Mechanism of Hashimoto's Thyroiditis Treated with Shutiao Qiji Decoction

Author(s): Shuang Guo*, Yan Lv, Junyu Shen, Rong Li, Haipeng Liu, Yuan Fan and Chunhong Tian

Volume 27, Issue 19, 2024

Published on: 30 October, 2023

Page: [2899 - 2911] Pages: 13

DOI: 10.2174/0113862073259714231012070100

open access plus

Abstract

Background: In recent years, the number of patients with Hashimoto's thyroiditis has been increasing, and traditional Chinese medicine ingredients and combinations have been applied to treat Hashimoto's thyroiditis to increase efficacy and reduce side effects during the treatment process.

Objective: Shutiao Qiji Decoction is one of the Chinese traditional medicine prescriptions, which is commonly used to treat cancer, tumor, etc. It is also used for thyroid-related diseases in the clinic. Hashimoto’s thyroiditis is an autoimmune disease. In this study, the mechanism of Shutiao Qiji Decoction in treating Hashimoto's thyroiditis was studied through network pharmacology and molecular docking verification.

Method: Each Chinese medicine ingredient of Shutiao Qiji Decoction was retrieved from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database. The related genes of HT were searched from the UniProt and GeneCards databases. Meanwhile, we used Cytoscape to construct the protein-protein interaction (PPI) visual network analysis, and used the search tool to search the database of Interacting Genes (STRING) to build a PPI network. These key proteins were enriched and analyzed by molecular docking validation, Gene Ontology (GO), and the Kyoto Encyclopedia of Genes and Genomes (KEGG). Hashimoto's thyroiditis disease model was established in SD rats, and SQD was administered by gavage after the successful establishment of the model. After 6 weeks of continuous administration of the drug by gavage, tissue samples were collected and the thyroid and spleen tissues were visualized by HE staining to verify the therapeutic effect.

Results: The results showed that there were 287 TCM active ingredients, 1920 HT-related disease targets, and 176 drug and disease targets in SQD. Through PPI analysis, GP analysis, and KEGG analysis of the common targets of drugs and diseases, we found their pathways of action to be mainly cancer action pathway, PI3K-AKT signaling pathway, and T-cell action pathway. The active ingredients of the drugs in SQD, malvidin, stigmasterol, porin-5-en-3bta-ol, and chrysanthemum stigmasterol, were docked with the related target proteins, MAPK, GSK3β, TSHR, and NOTCH molecules. The best binding energies obtained from docking were mairin with TSHR, stigmasterol with TSHR, poriferast-5-en-3beta-ol with MAPK, and chryseriol with GSK3β, with binding energies of -6.84 kcal/mol, -6.53 kcal/mol, -5.03 kcal/mol, and -5.05 kcal/mol, respectively. HE staining sections of rat thyroid and spleen tissues showed that SQD had a therapeutic effect on Hashimoto's thyroiditis and restored its immune function.

Conclusion: It is verified by molecular docking results that Shutiao Qiji Decoction has a potential therapeutic effect on Hashimoto's thyroiditis in the MAPK/TSHR/NOTCH signal pathway, and that the main components, mairin, stigmasterol, poriferast-5-en-3beta-ol, and chryseriol play a role in it. SQD has been shown to have a good therapeutic effect on Hashimoto's thyroiditis.

[1]
Jin, B.; Wang, S.; Fan, Z. Pathogenesis markers of hashimoto’s disease-a mini review. Frontiers in Bioscience-Landmark, 2022, 27(10), 297.
[http://dx.doi.org/10.31083/j.fbl2710297] [PMID: 36336870]
[2]
Mincer, D.L.; Jialal, I. Hashimoto Thyroiditis. In: In: StatPearls; StatPearls Publishing: Treasure Island, FL, 2022.
[3]
Weetman, A.P. An update on the pathogenesis of Hashimoto’s thyroiditis. J. Endocrinol. Invest., 2021, 44(5), 883-890.
[http://dx.doi.org/10.1007/s40618-020-01477-1] [PMID: 33332019]
[4]
Ragusa, F.; Fallahi, P.; Elia, G. Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract. Res. Clin. Endocrinol. Metab., 2019, 33(6), 101367.
[http://dx.doi.org/10.1016/j.beem.2019.101367] [PMID: 31812326]
[5]
Li, X.; Li, X.; Huang, N.; Liu, R.; Sun, R. A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins. Phytomedicine, 2018, 50, 73-87.
[http://dx.doi.org/10.1016/j.phymed.2018.09.174] [PMID: 30466994]
[6]
Lu, J.; Li, W.; Gao, T.; Wang, S.; Fu, C.; Wang, S. The association study of chemical compositions and their pharmacological effects of Cyperi Rhizoma (Xiangfu), a potential traditional Chinese medicine for treating depression. J. Ethnopharmacol., 2022, 287, 114962.
[http://dx.doi.org/10.1016/j.jep.2021.114962] [PMID: 34968659]
[7]
Ao, M.; Li, X.; Liao, Y. Curcumae Radix: A review of its botany, traditional uses, phytochemistry, pharmacology and toxicology. J. Pharm. Pharmacol., 2022, 74(6), 779-792.
[http://dx.doi.org/10.1093/jpp/rgab126] [PMID: 34633034]
[8]
Ma, J.; Chen, X.; Bian, Y.Q. Study on efficacy markers of Salviae Miltiorrhizae Radix et Rhizoma for promoting blood circulation and remving blood stasis based on systematic traditional Chinese medicine Zhongguo Zhong Yao Za Zhi, 2020, 45(14), 3259-3265.
[http://dx.doi.org/10.19540/j.cnki.cjcmm.20200210.404]
[9]
Zheng, Y.Q.; Zeng, J.X.; Lin, J.X. Herbal textual research on chuanxiong rhizoma in Chinese classical prescriptions. Zhongguo Zhong Yao Za Zhi, 2021, 46(16), 4293-4299.
[http://dx.doi.org/10.19540/j.cnki.cjcmm.20210523.104]
[10]
Liu, L.; Wang, Y.; Tan, C.; Han, X.; Dou, D. Substance basis of warm nature of Poria cocos. Chin. Herb. Med., 2020, 12(3), 316-325.
[http://dx.doi.org/10.1016/j.chmed.2020.04.002] [PMID: 36119008]
[11]
Zhu, B.; Zhang, Q.; Hua, J.; Cheng, W.; Qin, L. The traditional uses, phytochemistry, and pharmacology of Atractylodes macrocephala Koidz.: A review. J. Ethnopharmacol., 2018, 226, 143-167.
[http://dx.doi.org/10.1016/j.jep.2018.08.023] [PMID: 30130541]
[12]
Li, P.; Tsang, M.S.M.; Kan, L.L.Y. The immuno-modulatory activities of pentaherbs formula on ovalbumin-induced allergic rhinitis mice via the activation of th1 and treg cells and inhibition of Th2 and Th17 cells. Molecules, 2021, 27(1), 239.
[http://dx.doi.org/10.3390/molecules27010239] [PMID: 35011470]
[13]
Chen, S.Y.; Zhou, Q.Y.J.; Chen, L.; Liao, X.; Li, R.; Xie, T. The Aurantii Fructus Immaturus flavonoid extract alleviates inflammation and modulate gut microbiota in DSS-induced colitis mice. Front. Nutr., 2022, 9, 1013899.
[http://dx.doi.org/10.3389/fnut.2022.1013899] [PMID: 36276817]
[14]
Gao, Y.; Shi, W.; Tu, C. Immunostimulatory activity and structure-activity relationship of epimedin B from Epimedium brevicornu Maxim. Front. Pharmacol., 2022, 13, 1015846.
[http://dx.doi.org/10.3389/fphar.2022.1015846] [PMID: 36386137]
[15]
Ding, Y.; Brand, E.; Wang, W.; Zhao, Z. Licorice: Resources, applications in ancient and modern times. J. Ethnopharmacol., 2022, 298, 115594.
[http://dx.doi.org/10.1016/j.jep.2022.115594] [PMID: 35934191]
[16]
Xu, J.X.; Xu, J.; Cao, Y. Modern research progress of traditional Chinese medicine Paeoniae Radix Alba and prediction of its Q-markers. Zhongguo Zhong Yao Za Zhi, 2021, 46(21), 5486-5495.
[http://dx.doi.org/10.19540/j.cnki.cjcmm.20210818.201]
[17]
Zhang, D.; Zhang, Y.; Zhang, C. Discussion on the treatment of depression in traditional Chinese medicine with Zhang Zhenshu Tiaoqi Decoction, a Chinese medical master. Yunnan J Tradit Chin Med, 2021, 42(12), 12-14.
[http://dx.doi.org/10.16254/j.cnki.53-1120/r.2021.12.005]
[18]
Pu, W. The experience of Zhang Zhen, a Chinese medical master, in treating infertility based on the theory of regulating qi. Yunnan J Tradit Chin Med, 2022, 43(9), 4-7.
[http://dx.doi.org/10.16254/j.cnki.53-1120/r.2022.09.002]
[19]
Nogales, C.; Mamdouh, Z.M.; List, M.; Kiel, C.; Casas, A.I.; Schmidt, H.H.H.W. Network pharmacology: Curing causal mechanisms instead of treating symptoms. Trends Pharmacol. Sci., 2022, 43(2), 136-150.
[http://dx.doi.org/10.1016/j.tips.2021.11.004] [PMID: 34895945]
[20]
Wang, Z.Y.; Wang, X.; Zhang, D.Y. Traditional Chinese medicine network pharmacology: Development in new era under guidance of network pharmacology evaluation method guidance. Zhongguo Zhong Yao Za Zhi, 2022, 47(1), 7-17.
[http://dx.doi.org/10.19540/j.cnki.cjcmm.20210914.702]
[21]
Jiashuo, W.U.; Fangqing, Z.; Zhuangzhuang, L.I.; Weiyi, J.; Yue, S. Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review. J. Tradit. Chin. Med., 2022, 42(3), 479-486. [J].
[http://dx.doi.org/10.19852/j.cnki.jtcm.20220408.003] [PMID: 35610020]
[22]
Kahaly, G.J.; Diana, T.; Olivo, P.D. TSH receptor antibodies: Relevance & utility. Endocr. Pract., 2020, 26(1), 97-106.
[http://dx.doi.org/10.4158/EP-2019-0363] [PMID: 32022598]
[23]
Zhou, Y.; Shen, H.; Lan, W.; Shi, Y.; Yao, Q.; Wen, W. Mechanism of Xiaoying Daotan decoction in treating Hashimoto’s thyroiditis based on the Notch/Treg/Th17 pathway. Ann. Transl. Med., 2021, 9(24), 1760.
[http://dx.doi.org/10.21037/atm-21-6253] [PMID: 35071454]
[24]
Hu, X.; Chen, Y.; Shen, Y.; Tian, R.; Sheng, Y.; Que, H. Global prevalence and epidemiological trends of Hashimoto’s thyroiditis in adults: A systematic review and meta-analysis. Front. Public Health, 2022, 10, 1020709.
[http://dx.doi.org/10.3389/fpubh.2022.1020709] [PMID: 36311599]
[25]
Martinez Quintero, B.; Yazbeck, C.; Sweeney, L.B. Thyroiditis: Evaluation and treatment. Am. Fam. Physician, 2021, 104(6), 609-617.
[PMID: 34913664]
[26]
Du, P.; Xu, J.; Jiang, Y. Saikosaponin-d attenuates hashimoto’s thyroiditis by regulating macrophage polarization. J. Immunol. Res., 2022, 2022, 1-12.
[http://dx.doi.org/10.1155/2022/7455494] [PMID: 36398316]
[27]
Zhu, G.; Li, Y.; Gao, Y. Treatment of malignant tumors based on the theory of “one body, two wings, and qi regulating mechanism. J. Tradit. Chin. Med., 2020, 35(10), 5046-5049.
[28]
Hordyjewska, A.; Prendecka-Wróbel, M.; Kurach, Ł. Antiproliferative properties of triterpenoids by ECIS method—a new promising approach in anticancer studies? Molecules, 2022, 27(10), 3150.
[http://dx.doi.org/10.3390/molecules27103150] [PMID: 35630627]
[29]
Bakrim, S.; Benkhaira, N.; Bourais, I. Health benefits and pharmacological properties of stigmasterol. Antioxidants, 2022, 11(10), 1912.
[http://dx.doi.org/10.3390/antiox11101912] [PMID: 36290632]
[30]
Zhang, R.T.; Wu, H.N.; Yu, G.H. Effective components and signaling pathways of Epimedium brevicornumbased on network pharmacology. Zhongguo Zhong Yao Za Zhi, 2018, 43(23), 4709-4717.
[http://dx.doi.org/10.19540/j.cnki.cjcmm.20180905.001]
[31]
Aboulaghras, S.; Sahib, N.; Bakrim, S. Health benefits and pharmacological aspects of chrysoeriol. Pharmaceuticals, 2022, 15(8), 973.
[http://dx.doi.org/10.3390/ph15080973] [PMID: 36015121]
[32]
Xinyi, L.I. Treatment of Hashimoto’s thyroiditis from spleen theory. Jiangsu Tradit Chin Med, 2023, 55(07), 49-52.
[http://dx.doi.org/10.19844/j.cnki.1672-397X.2023.07.014]

© 2025 Bentham Science Publishers | Privacy Policy